Close this search box.

Venture Report: Blackstone eyes pipeline-in-a-product via Uniquity launch

ARTICLE | Finance

Plus: New funds for Sands and NewVale, and series C rounds for Lycia and Ajax

By Paul Bonanos, Director of Biopharma Intelligence

May 16, 2024 9:25 PM UTC

An immunology start-up emerged from stealth with a large commitment from Blackstone, and two firms announced new funds this week to foster biotech start-ups’ growth.

Blackstone Life Sciences has committed up to $300 million to newly launched Uniquity Bio Inc., a company advancing an antibody that could  have advantages over others in the anti-TSLP class to treat immune and inflammatory diseases, starting with COPD and asthma…